2022. A new paradigm of cardiohematological monitoring in patients with chronic myeloid leukemia taking tyrosine kinase inhibitors. Ukrainian Journal of Cardiology. 29, 1-2 (Jul. 2022), 72–86. DOI:https://doi.org/10.31928/1608-635X-2022.1-2.7286.